Earnings tape
The tape is still simple: miss with soft commentary gets punished, while a beat mostly just earns you the right to be ignored.
Ad tech acted like ad tech when budgets feel optional. The Trade Desk (TTD) sold off after Q2 earnings and revenue missed and guidance leaned soft. That’s a direct hit to the “real-time demand signal” pitch. The market bought numbers, not hope.
Healthcare software was the same setup. Health Catalyst (HCAT) fell on profitability deterioration despite a small revenue beat. Q2 GAAP EPS -$0.55 (miss by $0.40) with revenue $70.4M (beat by $1.36M) puts the cost base back on trial and raises questions about implementation cadence and operating leverage.
In Canada, WELL Health (WELL.TO) was flat to down with the familiar tension: Q2 non-GAAP EPS $0.04 (miss by $0.02) while revenue $400.43M (beat by $13.8M). The top line is holding up; the stock needs a cleaner path from revenue to incremental profit. Today didn’t deliver it.
Consumer wellness leaned weak too. Nature’s Sunshine (NATR) moved lower after missing both lines (Q2 GAAP EPS $0.19, miss by $0.08; revenue $117M, miss by $6.72M). Discretionary demand plus shaky acquisition efficiency is not what you want to defend into a jittery tape.
Gaming, payments, media
Profit bridges matter more than the headline growth story.
Online gaming didn’t get much sympathy. DraftKings (DKNG) traded down after Q2 sales and earnings came in below estimates. The sector is increasingly underwritten on durable profitability, not “handle up, margins later.” A dual miss brings promo intensity and state-by-state margin variability right back to the center of the debate.
Payments offered a more muted version of the same theme. Priority Commerce (TSE:PRTY) was flat after reiterating long-dated targets while flagging near-term pressure. It maintained its 2026 revenue outlook of $1.01B–$1.04B but warned of margin pressure from investment and mix. That tends to cap the upside: targets are nice, but the market wants a short, believable path to profits.
Media was mostly a shrug. Lionsgate Studios (LGF.A) was flat after Q2 non-GAAP EPS $0.06 and a small profit—no big forward reset, no big reaction. E.W. Scripps also reported Q2 results (no headline figures in the summary), with the same moving parts still driving the story: ad demand and retrans dynamics.
Beats and corporate action
A few prints were simply steadier. CES Energy Solutions (CESDF) was flat after Q2 GAAP EPS C$0.18 on revenue C$714.1M. More confirmation than catalyst; the name still trades on activity and pricing power.
Insurance brought real quality. American International Group (AIG) traded up on a Q2 profit beat tied to strong underwriting. That’s the kind of upside investors trust because it’s operational, not a markets coin flip.
GoodRx (GDRX) was up to flat after stronger earnings driven by strategic partnerships even as the legacy prescription segment declined. Investors will pay for the pivot if the replacement engine scales fast enough to outrun the runoff, and this print helped.
Corporate action gave cleaner direction than most calls. Jamieson Wellness (JAM) traded up on a deal to be acquired by Kirin Holdings for C$2B ($1.4B). Strategic buyers are still writing checks for cash-flowing consumer health, even if public multiples stay selective.
In semis/AI, AMD was flat to up after announcing it will acquire Taalas to improve AI inference performance via model siliconization. The reaction was muted: capability add, not an immediate revenue jolt.
Macro was mostly quiet, but the next obvious catalyst is labor. US July nonfarm payrolls are forecast at +83,000, with unemployment expected at 4.2%. Until that hits, the playbook stays the same: punish margin misses, ignore “fine” quarters, and pay up only when the earnings power is clearly improving.
What mattered
- Misses with margin slippage got hit: TTD, HCAT, NATR, DKNG.
- In-line prints mostly went nowhere: CESDF, LGF.A, WELL.TO.
- Quality upside came from underwriting and strategic pivots: AIG, GDRX.
- M&A still clears when the asset is clean: JAM; AMD added AI inference tooling without moving the tape much.